Pfizer Expects Pliant Partners: Deferring To Pfizer Skills And Strengths

Pfizer expects its partners to defer to Pfizer in areas where it has a clear advantage in established skills and size, rather than push the joint arrangements as a way for the smaller firm to develop new functions